T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
MetLife
MET
$61.4B
| $1.85B | 0.3% |
25,610,023
+5,444,254
| +27% | +$390M |
|
77
Pfizer
PFE
$150B
| $1.84B | 0.3% |
35,872,541
-595,448
| -2% | -$28.5M |
|
78
EOG Resources
EOG
$75.1B
| $1.8B | 0.29% |
13,911,070
-824,683
| -6% | -$110M |
|
79
Qualcomm
QCOM
$171B
| $1.74B | 0.28% |
15,862,203
-2,982,325
| -16% | -$349M |
|
80
Ferrari
RACE
$71.6B
| $1.74B | 0.28% |
8,137,521
+48,320
| +0.6% | +$9.96M |
|
81
Synopsys
SNPS
$79B
| $1.72B | 0.28% |
5,390,414
-1,530,937
| -22% | -$479M |
|
82
HCA Healthcare
HCA
$89.8B
| $1.69B | 0.27% |
7,039,618
+1,734,194
| +33% | +$388M |
|
83
Progressive
PGR
$121B
| $1.63B | 0.26% |
12,573,997
+608,635
| +5% | +$77.1M |
|
84
Nutrien
NTR
$32.1B
| $1.61B | 0.26% |
21,985,300
+1,811,511
| +9% | +$143M |
|
85
Las Vegas Sands
LVS
$29.6B
| $1.61B | 0.26% |
33,393,752
+1,539,069
| +5% | +$65.3M |
|
86
Ingersoll Rand
IR
$32.9B
| $1.59B | 0.26% |
30,462,884
+1,651,634
| +6% | +$84.3M |
|
87
Honeywell
HON
$74.6B
| $1.54B | 0.25% |
7,606,928
-602,704
| -7% | -$115M |
|
|
MRSH
88
Marsh
MRSH
$90.1B
| $1.52B | 0.24% |
9,188,078
+735,798
| +9% | +$120M |
|
89
Ameren
AEE
$30.1B
| $1.52B | 0.24% |
17,091,049
+8,513
| +0% | +$715K |
|
90
argenx
ARGX
$54.8B
| $1.5B | 0.24% |
3,959,686
-279,003
| -7% | -$104M |
|
91
Travelers Companies
TRV
$77.2B
| $1.47B | 0.24% |
7,820,386
+829,918
| +12% | +$149M |
|
92
Weyerhaeuser
WY
$17.8B
| $1.44B | 0.23% |
46,308,945
+6,333,675
| +16% | +$196M |
|
|
93
US Bancorp
USB
$101B
| $1.43B | 0.23% |
32,756,814
+29,521,176
| +912% | +$1.26B |
|
94
Zimmer Biomet
ZBH
$18.7B
| $1.43B | 0.23% |
11,200,109
+650,886
| +6% | +$75.5M |
|
|
95
Lam Research
LRCX
$408B
| $1.42B | 0.23% |
33,894,850
+28,313,810
| +507% | +$1.18B |
|
96
Prologis
PLD
$134B
| $1.41B | 0.23% |
12,480,030
-590,974
| -5% | -$65.5M |
|
|
DAY
97
DELISTED
Dayforce
DAY
| $1.39B | 0.22% |
21,691,635
+3,273,796
| +18% | +$206M |
|
98
United Parcel Service
UPS
$88.4B
| $1.36B | 0.22% |
7,828,307
-1,201,158
| -13% | -$208M |
|
99
Vertex Pharmaceuticals
VRTX
$133B
| $1.36B | 0.22% |
4,697,667
-460,287
| -9% | -$140M |
|
|
HES
100
DELISTED
Hess
HES
| $1.34B | 0.22% |
9,480,828
+1,987,732
| +27% | +$273M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.